The current PE ratio of ENOV can't be determined, as the TTM EPS of -$14.93 is negative. The last PE ratio of Enovis, recorded in September 2022, was 112.37.
The PE ratio of Enovis has averaged 48.65 over the last ten years. In the past ten years, ENOV's PE ratio reached its highest point in the Dec 2020 quarter at 123.36, when the stock price was $114.72 and the EPS was $0.93. The lowest point was recorded in the Dec 2015 quarter, when it reached 17.3 with a price of $70.05 and an EPS of $4.05.
Maximum annual increase: 472.35% in 2011
Maximum annual decrease: -58.73% in 2014
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | N/A | N/A | $43.88 | -$14.93 |
2023 | N/A | N/A | $56.02 | -$0.61 |
2022 | N/A | N/A | $53.52 | -$0.25 |
2021 | 98.51 | -20.14% | $137.91 | $1.4 |
2020 | 123.36 | N/A | $114.72 | $0.93 |
2019 | N/A | N/A | $109.14 | -$11.67 |
2018 | 17.86 | -44.55% | $62.7 | $3.51 |
2017 | 32.21 | -6.77% | $118.86 | $3.69 |
2016 | 34.55 | 99.71% | $107.79 | $3.12 |
2015 | 17.3 | 2.67% | $70.05 | $4.05 |
2014 | 16.85 | -58.73% | $154.71 | $9.18 |
2013 | 40.83 | N/A | $191.07 | $4.68 |
2012 | N/A | N/A | $121.05 | -$2.76 |
2011 | 284.8 | 472.35% | $85.44 | $0.3 |
2010 | 49.76 | 127.32% | $55.23 | $1.11 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | N/A | N/A | $43.88 | -$14.93 |
Sep 2024 | N/A | N/A | $43.63 | -$2.18 |
Jun 2024 | N/A | N/A | $45.2 | -$1.65 |
Mar 2024 | N/A | N/A | $62.45 | -$1.49 |
Dec 2023 | N/A | N/A | $56.02 | -$0.61 |
Sep 2023 | N/A | N/A | $52.73 | -$1.38 |
Jun 2023 | N/A | N/A | $64.12 | -$2.56 |
Mar 2023 | N/A | N/A | $53.49 | -$0.96 |
Dec 2022 | N/A | N/A | $53.52 | -$0.25 |
Sep 2022 | 112.37 | 327.42% | $46.07 | $0.41 |
Jul 2022 | 26.29 | -72.58% | $56 | $2.13 |
Apr 2022 | 95.88 | -2.67% | $121.77 | $1.27 |
Dec 2021 | 98.51 | 52.02% | $137.91 | $1.4 |
Oct 2021 | 64.8 | -8.5% | $141.27 | $2.18 |
Jul 2021 | 70.82 | -33.48% | $140.94 | $1.99 |
Stock name | PE ratio | Market cap |
---|---|---|
NVRO Nevro Corp | N/A | $221.4M |
OFIX Orthofix Medical Inc | N/A | $619.87M |
NURO NeuroMetrix Inc | N/A | $9.19M |
ENOV Enovis Corp | N/A | $2B |
The current price to earnings ratio of ENOV can't be calculated, as its EPS of -$14.93 is negative.
As an average over the last 5 years, ENOV stock has a PE ratio of 87.31.
Over the last ten years, the quarterly PE ratio reached a historic high of 123.36 in the Dec 2020 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.